TY - JOUR
T1 - Denosumab for preventing fractures in postmenopausal women with osteoporosis
AU - Yanai, Ryo
AU - Okabayashi, Shinji
AU - Luo, Yan
AU - Fujii, Kotaro
AU - Miyawaki, Yoshia
AU - Yajima, Nobuyuki
AU - Watanabe, Norio
N1 - Funding Information:
The authors thank the Cochrane Musculoskeletal Group for their guidance in developing this protocol. The authors thank Joey SW Kwong and the Cochrane Japan Centre for assisting with English editing. Elements of the methods section are based on the standard Cochrane Musculoskeletal Group Protocol Template developed by the Cochrane Musculoskeletal Group editorial base. We acknowledge peer reviewers Professor Tania Winzenberg, Professor in Chronic Disease Management, Menzies Institute for Medical Research, Tasmania, and Mr Ambrish Singh, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia. We acknowledge copy editor Luisa M Fernandez Mauleffinch, Cochrane Central Production Service.
Publisher Copyright:
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2022/9/15
Y1 - 2022/9/15
N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of denosumab, compared to placebo or other active comparators, for preventing fractures in postmenopausal women with osteoporosis.
AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of denosumab, compared to placebo or other active comparators, for preventing fractures in postmenopausal women with osteoporosis.
UR - http://www.scopus.com/inward/record.url?scp=85138220115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138220115&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD014680
DO - 10.1002/14651858.CD014680
M3 - Article
AN - SCOPUS:85138220115
SN - 1361-6137
VL - 2022
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 9
M1 - CD014680
ER -